Different sensitivities of various thromboplastins to two blood collection systems for monitoring oral anticoagulant therapy. 1999

A M van den Besselaar, and R M Bertina, and F J van der Meer, and J den Hartigh

UI MeSH Term Description Entries
D001800 Blood Specimen Collection The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc. Blood Specimen Collections,Collection, Blood Specimen,Collections, Blood Specimen,Specimen Collection, Blood,Specimen Collections, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D013925 Thromboplastin Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation. Antigens, CD142,CD142 Antigens,Coagulation Factor III,Factor III,Tissue Factor,Tissue Thromboplastin,Blood Coagulation Factor III,Coagulin,Glomerular Procoagulant Activity,Prothrombinase,Tissue Factor Procoagulant,Urothromboplastin,Activity, Glomerular Procoagulant,Factor III, Coagulation,Procoagulant Activity, Glomerular,Procoagulant, Tissue Factor,Thromboplastin, Tissue
D016903 Drug Monitoring The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically. Monitoring, Drug,Therapeutic Drug Monitoring,Drug Monitoring, Therapeutic,Monitoring, Therapeutic Drug

Related Publications

A M van den Besselaar, and R M Bertina, and F J van der Meer, and J den Hartigh
January 1990, Annales de biologie clinique,
A M van den Besselaar, and R M Bertina, and F J van der Meer, and J den Hartigh
June 2011, Clinical chemistry,
A M van den Besselaar, and R M Bertina, and F J van der Meer, and J den Hartigh
January 2004, The hematology journal : the official journal of the European Haematology Association,
A M van den Besselaar, and R M Bertina, and F J van der Meer, and J den Hartigh
October 1980, Pathology,
A M van den Besselaar, and R M Bertina, and F J van der Meer, and J den Hartigh
April 1995, [Rinsho ketsueki] The Japanese journal of clinical hematology,
A M van den Besselaar, and R M Bertina, and F J van der Meer, and J den Hartigh
November 1958, Thrombosis et diathesis haemorrhagica,
A M van den Besselaar, and R M Bertina, and F J van der Meer, and J den Hartigh
August 1957, Circulation,
A M van den Besselaar, and R M Bertina, and F J van der Meer, and J den Hartigh
August 1971, American journal of clinical pathology,
A M van den Besselaar, and R M Bertina, and F J van der Meer, and J den Hartigh
January 2010, Journal of blood medicine,
A M van den Besselaar, and R M Bertina, and F J van der Meer, and J den Hartigh
January 1981, Das Medizinische Laboratorium,
Copied contents to your clipboard!